(NASDAQ: HSIC) Henry Schein's forecast annual revenue growth rate of 3.87% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.42%.
Henry Schein's revenue in 2024 is $12,487,000,000.On average, 9 Wall Street analysts forecast HSIC's revenue for 2024 to be $1,635,046,434,550, with the lowest HSIC revenue forecast at $1,626,005,706,383, and the highest HSIC revenue forecast at $1,645,060,025,197. On average, 9 Wall Street analysts forecast HSIC's revenue for 2025 to be $1,702,799,502,123, with the lowest HSIC revenue forecast at $1,673,668,112,055, and the highest HSIC revenue forecast at $1,726,885,767,759.
In 2026, HSIC is forecast to generate $1,773,799,710,462 in revenue, with the lowest revenue forecast at $1,732,189,376,101 and the highest revenue forecast at $1,817,775,426,014.